AURA earnings date and last-quarter result: next report 2026-08-12, last quarter miss, P/E -3.96. Updated 2026-07-23.
Aura Biosciences (AURA) Research Hub
Aura Biosciences (AURA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 6.18 USD (-1.90%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.96, market cap 0.45B. This hub links to the full technical, earnings and options research available for AURA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 6.18 USD (-1.90%) |
| 52-week range | 5.95 USD – 8.37 USD |
| Trend regime | Range |
| 14-day RSI | 50.3 (Neutral) |
| Trailing P/E | -3.96 |
| Market cap | 0.45B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for AURA
Covered Call on AURA: how it works, illustrative setup around the real 6.18 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on AURA: how it works, illustrative setup around the real 6.18 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on AURA: how it works, illustrative setup around the real 6.18 USD price, max profit/loss, breakeven and when to use it. Educational.
AURA technical analysis: range, last 6.18 USD, RSI 50.3, 52w range 5.95 USD–8.37 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is AURA in?
Aura Biosciences (AURA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is AURA in an uptrend or downtrend?
As of 2026-10-26, AURA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is AURA's trailing P/E ratio?
AURA's trailing P/E is -3.96, with a market cap of 0.45B. See the earnings research page for full valuation detail.
When does AURA next report earnings?
AURA is next scheduled to report earnings on 2026-08-12.